Literature DB >> 1096754

Clinical pharmacology of digitalis glycosides.

J E Doherty, J J Kane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1096754     DOI: 10.1146/annurev.me.26.020175.001111

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  10 in total

1.  Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?

Authors:  J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

2.  Digoxin dose precision: prescribing aids or intuition?

Authors:  G D Johnston
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

3.  Digitalis intoxication.

Authors:  M G Thorne; C E Bowman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18

4.  Monitoring digoxin therapy: III. How useful are the nomograms?

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

5.  Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.

Authors:  J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

7.  The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.

Authors:  N M Griffiths; D S Hewick; J F Lamb; I H Stevenson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

8.  Haemodynamic effects of ICI 118,587 in cardiomyopathy.

Authors:  S Simonsen
Journal:  Br Heart J       Date:  1984-06

9.  Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.

Authors:  J O Magnusson; B Bergdahl; C Bogentoft; S Gustafsson; U E Jonsson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Development and Validation of a UHPLC-ESI-MS/MS Method for Quantification of Oleandrin and Other Cardiac Glycosides and Evaluation of Their Levels in Herbs and Spices from the Belgian Market.

Authors:  Svetlana V Malysheva; Patrick P J Mulder; Julien Masquelier
Journal:  Toxins (Basel)       Date:  2020-04-09       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.